BLUE
Rrefiningvalue.bsky.social

Commercialization risk is very real and often underdiscussed outside investment circles imo including in general pharma pricing/value discussions #biosky

0
Rrefiningvalue.bsky.social

Evolving models for innovative drugs; on direct-to-consumer offerings by pharma #bioskyopen.substack.com/pub/refining...

Evolving models for innovative drugs
Evolving models for innovative drugs

On direct-to-consumer offerings from pharma

0
PFpearlf.bsky.social

Amgen's EVP R&D & Chief Scientific Officer Jay Bradner is in Boston on Wednesday 10/2 & is giving the keynote at Harvard Medical School's Harvard Biotech Club at 10:00 AM ET. The registration link is below for his talk & the career fair. #bioskyharvardbiotechclub.typeform.com/to/ff2ccpRH?...

0
PBbiobonanos.bsky.social

And in Barcelona, Asabys Partners announced this week that it had closed its €180m second fund, to be invested in 12-15 companies in Europe. #biosky#biotech

1